These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12645339)

  • 1. CD105 expression is a marker of high metastatic risk and poor outcome in breast carcinomas. Correlations between immunohistochemical analysis and long-term follow-up in a series of 929 patients.
    Dales JP; Garcia S; Bonnier P; Duffaud F; Andrac-Meyer L; Ramuz O; Lavaut MN; Allasia C; Charpin C
    Am J Clin Pathol; 2003 Mar; 119(3):374-80. PubMed ID: 12645339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The immunohistochemical expression of CD105 is a marker for high metastatic risk and worse prognosis in breast cancers].
    Charpin-Taranger C; Dales JP; Garcia S; Andrac-Meyer L; Ramuz O; Carpentier-Meunier S; Bonnier P
    Bull Acad Natl Med; 2003; 187(6):1129-45; discussion 1145-6. PubMed ID: 14978873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome.
    Dales JP; Garcia S; Andrac L; Carpentier S; Ramuz O; Lavaut MN; Allasia C; Bonnier P; Charpin C
    Int J Oncol; 2004 May; 24(5):1197-204. PubMed ID: 15067342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tie2/Tek expression in breast carcinoma: correlations of immunohistochemical assays and long-term follow-up in a series of 909 patients.
    Dales JP; Garcia S; Bonnier P; Duffaud F; Meunier-Carpentier S; Andrac-Meyer L; Lavaut MN; Allasia C; Charpin C
    Int J Oncol; 2003 Feb; 22(2):391-7. PubMed ID: 12527939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term prognostic significance of neoangiogenesis in breast carcinomas: comparison of Tie-2/Tek, CD105, and CD31 immunocytochemical expression.
    Dales JP; Garcia S; Carpentier S; Andrac L; Ramuz O; Lavaut MN; Allasia C; Bonnier P; Charpin C
    Hum Pathol; 2004 Feb; 35(2):176-83. PubMed ID: 14991534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor neoangiogenesis by CD31 and CD105 expression evaluation in breast carcinoma tissue microarrays.
    Charpin C; Dales JP; Garcia S; Carpentier S; Djemli A; Andrac L; Lavaut MN; Allasia C; Bonnier P
    Clin Cancer Res; 2004 Sep; 10(17):5815-9. PubMed ID: 15355911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas.
    Salvesen HB; Gulluoglu MG; Stefansson I; Akslen LA
    APMIS; 2003 Nov; 111(11):1011-8. PubMed ID: 14629267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoglin (CD 105) as a potential prognostic factor in neuroblastoma.
    Ćavar S; Jelašić D; Seiwerth S; Milošević M; Hutinec Z; Mišić M
    Pediatr Blood Cancer; 2015 May; 62(5):770-5. PubMed ID: 25683142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of carbonic anhydrase IX (CA-IX), endoglin (CD105) and 8-hydroxy-2'-deoxyguanosine (8-OHdG) in breast cancer patients.
    Beketic-Oreskovic L; Ozretic P; Rabbani ZN; Jackson IL; Sarcevic B; Levanat S; Maric P; Babic I; Vujaskovic Z
    Pathol Oncol Res; 2011 Sep; 17(3):593-603. PubMed ID: 21249485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905).
    Dales JP; Garcia S; Carpentier S; Andrac L; Ramuz O; Lavaut MN; Allasia C; Bonnier P; Taranger-Charpin C
    Br J Cancer; 2004 Mar; 90(6):1216-21. PubMed ID: 15026804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD105 (Endoglin) expression in breast carcinoma effusions is a marker of poor survival.
    Davidson B; Stavnes HT; Førsund M; Berner A; Staff AC
    Breast; 2010 Dec; 19(6):493-8. PubMed ID: 21078485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD31/PECAM automated and quantitative immunocytochemical assays in breast carcinomas: correlation with patient follow-up.
    Charpin C; Garcia S; Bouvier C; Martini F; Andrac L; Bonnier P; Lavaut MN; Allasia C
    Am J Clin Pathol; 1997 May; 107(5):534-41. PubMed ID: 9128265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta binding receptor endoglin (CD105) expression in esophageal cancer and in adjacent nontumorous esophagus as prognostic predictor of recurrence.
    Bellone G; Solerio D; Chiusa L; Brondino G; Carbone A; Prati A; Scirelli T; Camandona M; Palestro G; Dei Poli M
    Ann Surg Oncol; 2007 Nov; 14(11):3232-42. PubMed ID: 17682823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis.
    Li C; Gardy R; Seon BK; Duff SE; Abdalla S; Renehan A; O'Dwyer ST; Haboubi N; Kumar S
    Br J Cancer; 2003 May; 88(9):1424-31. PubMed ID: 12778073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome.
    Martone T; Rosso P; Albera R; Migliaretti G; Fraire F; Pignataro L; Pruneri G; Bellone G; Cortesina G
    Oral Oncol; 2005 Feb; 41(2):147-55. PubMed ID: 15695116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic relevance of CD105-assessed microvessel density in laryngeal carcinoma.
    Zvrko E; Mikic A; Vuckovic L; Djukic V; Knezevic M
    Otolaryngol Head Neck Surg; 2009 Oct; 141(4):478-83. PubMed ID: 19786216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma].
    Li Q; Zhang B; Peng P
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of endoglin (CD105) expression in ovarian carcinoma.
    Taskiran C; Erdem O; Onan A; Arisoy O; Acar A; Vural C; Erdem M; Ataoglu O; Guner H
    Int J Gynecol Cancer; 2006; 16(5):1789-93. PubMed ID: 17009973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoglin (CD105) expression in human renal cell carcinoma.
    Sandlund J; Hedberg Y; Bergh A; Grankvist K; Ljungberg B; Rasmuson T
    BJU Int; 2006 Apr; 97(4):706-10. PubMed ID: 16536758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopathologic significance of CD105 mRNA expression in human breast carcinoma].
    Pang D; Liu F; Xue YW; Zhang QF
    Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):38-40. PubMed ID: 15771797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.